PHARMASEAL

company

About

PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
£1M
Industries
Biopharma,Health Care,Pharmaceutical
Founded date
Oct 10, 2016
Number Of Employee
11 - 50
Operating Status
Active

PHARMASEAL was born in 2016 with the mission to create a digital platform that enables their customers to increase control of their clinical trials and accelerate product development.

PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£1.50M
PHARMASEAL has raised a total of £1.50M in funding over 2 rounds. Their latest funding was raised on May 3, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 3, 2019 Series A £1M 1 Detail
Jan 23, 2018 Seed £500K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
PHARMASEAL is funded by 1 investors. Mercia Fund Managers are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Series A